4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-16-071335
CIK 0001572552operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 6:02 AM ET
Size
5.0 KB
Accession
0001140361-16-071335
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2016-06-30$2.40/sh+10,000$23,977→ 260,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.38 to $2.41, inclusive. The reporting person undertakes to provide to any stockholder of Asterias Biotherapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 6:02 AM ET
- Size
- 5.0 KB